Haloperidol decanoate and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Haloperidol decanoate (haloperidol decanoate), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Valproate Sodium, and have Schizophrenia.

The phase IV clinical study analyzes which people have Overdose when taking Haloperidol decanoate. It is created by eHealthMe based on reports of 1,886 people who have side effects when taking Haloperidol decanoate from the FDA, and is updated regularly.

What is Haloperidol decanoate?

Haloperidol decanoate has active ingredients of haloperidol decanoate. eHealthMe is studying from 1,890 Haloperidol decanoate users. Check the latest studies of Haloperidol decanoate.

What is Overdose?

Overdose is found to be associated with 2,225 drugs and 2,470 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 07, 2026

1,886 people reported to have side effects when taking Haloperidol decanoate.
Among them, 47 people (2.49%) have Overdose.

Could Haloperidol decanoate cause Overdose?

Among these 47 people:

How long have people been on Haloperidol decanoate when they have Overdose? *

What is the gender of people who have Overdose when taking Haloperidol decanoate? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Overdose when taking Haloperidol decanoate? *

What are other drugs people take besides Haloperidol decanoate? *

What are other side effects people have besides Overdose? *

Consciousness - Decreased: 7 people, 14.89%
Parkinson's Disease: 6 people, 12.77%
Suicide Attempt: 5 people, 10.64%
Delirium (wild excitement): 5 people, 10.64%
Drug Ineffective: 5 people, 10.64%
Hospitalisation: 4 people, 8.51%
Psychotic Disorder: 4 people, 8.51%
Memory Loss: 4 people, 8.51%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 4 people, 8.51%
Weakness: 4 people, 8.51%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 17.02%
Stress And Anxiety: 5 people, 10.64%
Psychotic Disorder: 5 people, 10.64%
Bipolar Disorder (mood disorder): 4 people, 8.51%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 4 people, 8.51%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 3 people, 6.38%
Mood Swings (an extreme or rapid change in mood): 3 people, 6.38%
Affective Disorder (mental disorder): 2 people, 4.26%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 2 people, 4.26%
Confusional State: 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol decanoate and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Haloperidol decanoate:

Haloperidol decanoate (1,890 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Haloperidol decanoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,225 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,470 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on haloperidol decanoate (the active ingredients of Haloperidol decanoate) and Haloperidol decanoate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.